Skip to main content
. 2022 Jul;74(3):462–505. doi: 10.1124/pharmrev.120.000236

Fig. 10.

Fig. 10

Effect of angiotensin (Ang) II type 1 receptor blockade with losartan, angiotensin-converting enzyme inhibition with captopril, angiotensinogen (AGT) siRNA, or their combination during 4 weeks on the levels of Ang I, Ang II, Ang III, and Ang-(1-7) in blood and kidney of five-sixths nephrectomy rats. Modified from Bovée et al. (2021). *P < 0.05, **P < 0.01, ***P < 0.001 vs. vehicle. LLOQ, lower limit of quantification.